NCT01906593View on ClinicalTrials.gov

A Post-marketing Safety Study of Beijing Tiantan Biological's Influenza Virus Vaccine in Elderly

CompletedOBSERVATIONAL
Enrollment

536,812

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
InfluenzaVaccination Adverse Event
All Listed Sponsors
collaborator

Beijing Tiantan Biological Products Co., Ltd.

INDUSTRY

lead

Centers for Disease Control and Prevention, China

OTHER_GOV

NCT01906593 - A Post-marketing Safety Study of Beijing Tiantan Biological's Influenza Virus Vaccine in Elderly | Biotech Hunter | Biotech Hunter